By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Galenea 

790 Memorial Drive, Suite 202

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-374-1010 Fax: 617-374-1320


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Galenea Awarded $3 Million National Institutes of Health (NIH) Grant to Develop Translational EEG Biomarkers for Schizophrenia 9/6/2012 10:20:02 AM
Galenea and CHDI Foundation Announce Extension and Expansion of Huntington's Disease Collaboration 8/9/2012 10:32:45 AM
Timothy A. Ryan, PhD Joins Galenea's Scientific Advisory Board 7/16/2012 9:48:41 AM
Galenea and Eisai Company, Ltd. (ESALY.PK) Enter into Research Collaboration to Develop Synaptic Modulators for Neurodegenerative Diseases 7/10/2012 10:20:58 AM
Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program 4/26/2012 7:50:02 AM
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function 10/11/2011 8:09:35 AM
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function 10/6/2011 12:45:42 PM
Galenea Awarded Two SBIR Grants to Advance Innovative Approaches for the Discovery and Development of Effective Treatments for Schizophrenia 9/28/2011 10:44:04 AM
Galenea and CHDI Foundation Announce Collaboration to Identify Key Synaptic Dysfunction in Huntington's Disease 9/6/2011 11:58:02 AM
Galenea Awarded $4.5 Million Grant for Advancement of Innovative Synaptic Transmission Screen 10/15/2010 6:54:25 AM
123
//-->